Vimarsana
Biggest News Aggregation in the World

Page 12 - Integrative Screening Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrative Screening Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrative Screening Process Today - Breaking & Trending Today

IRLAB Therapeutics: IRLAB Reports That Board Member Leaves the Company's Board - Vimarsana News

IRLAB Therapeutics: IRLAB Reports That Board Member Leaves the Company's Board

GOTHENBURG, SE / ACCESSWIRE / February 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 21, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering

IRLAB Therapeutics: IRLAB Changes CEO and Appoints New Chairman - Vimarsana News

IRLAB Therapeutics: IRLAB Changes CEO and Appoints New Chairman

GOTHENBURG, SWEDEN / ACCESSWIRE / February 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 13, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering

IRLAB Therapeutics: IRLAB Updates on Portfolio Development Milestones - Vimarsana News

IRLAB Therapeutics: IRLAB Updates on Portfolio Development Milestones

GOTHENBURG, SWEDEN / ACCESSWIRE / February 13, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 13, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering

IRLAB Therapeutics: IRLAB Announces Top-Line Results from Phase IIb Trial of Mesdopetam in Parkinson's disease - Vimarsana News

IRLAB Therapeutics: IRLAB Announces Top-Line Results from Phase IIb Trial of Mesdopetam in Parkinson's disease

GOTHENBURG, SE / ACCESSWIRE / January 17, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) a company discovering and developing novel treatments for Parkinson's disease, today announced the top-line results

IRLAB Therapeutics: IRLAB Nominates IRL1117 As Drug Candidate from The P003 Project to Develop a Novel Treatment for Parkinson's Disease - Vimarsana News

IRLAB Therapeutics: IRLAB Nominates IRL1117 As Drug Candidate from The P003 Project to Develop a Novel Treatment for Parkinson's Disease

GOTHENBURG, SE / ACCESSWIRE / January 12, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 12, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering